Mrs Lisa Ann Gemma, CCC-SLP in Hope, RI - Speech-Language Pathologist

Mrs Lisa Ann Gemma, CCC-SLP is a Speech-language Pathologist based in Hope, Rhode Island. Mrs Lisa Ann Gemma is licensed to practice in Rhode Island (license number ) and her current practice location is 32 Eagle Dr, Hope, Rhode Island. She can be reached at her office (for appointments etc.) via phone at (401) 821-4903.

NPI number for Mrs Lisa Ann Gemma is 1043510068 and her current mailing address is 32 Eagle Dr, Hope, Rhode Island. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1043510068.

Contact Information

	Mrs Lisa Ann Gemma, CCC-SLP
	32 Eagle Dr, Hope, RI 02831-1353
	(401) 821-4903
	Not Available

Healthcare Provider's Profile

Full Name	Mrs Lisa Ann Gemma
Gender	Female
Speciality	Speech-language Pathologist
Location	32 Eagle Dr, Hope, Rhode Island
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1043510068
Provider Enumeration Date: 10/25/2010
Last Update Date: 10/25/2010

Medical Identifiers

Medical identifiers for Mrs Lisa Ann Gemma such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043510068	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	(Rhode Island)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Lisa Ann Gemma is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Lisa Ann Gemma, CCC-SLP 32 Eagle Dr, Hope, RI 02831-1353 Ph: (401) 821-4903	Mrs Lisa Ann Gemma, CCC-SLP 32 Eagle Dr, Hope, RI 02831-1353 Ph: (401) 821-4903

News Archive

Oak Point students raise $42,474.24 to combat cancer

Penny by penny, students at Oak Point Intermediate School in Eden Prairie, MN, raised an incredible $42,474.24 through Pennies for Patients, making them the top fundraiser nationwide in The Leukemia & Lymphoma Society's School & Youth Programs.

Brief interventions delivered in doctors' offices can lead to reductions in drinking

A new systematic review and meta-analysis has found that alcohol-targeted brief interventions (short, structured, one-to-one conversations about drinking designed to motivate changes in risky behavior) delivered in doctors' offices and similar medical settings can produce small but useful reductions in drinking.

AICAR might protect against heat stress in MH-susceptible individuals

Malignant hyperthermia (MH) is a life-threatening genetic muscle disorder, most commonly triggered in those at risk by certain types of drugs used during anesthesia. Heat stroke, on the other hand, most commonly occurs in individuals in response to physical exertion in hot/humid environments. While their common triggers may differ, the signs associated with MH and heat stroke are remarkably similar - uncontrolled muscle contractions, dangerous increases in body temperature, and muscle breakdown leading to the release of toxins in the blood which may cause cardiac arrhythmias and death. Immediate treatment for these conditions is crucial.

Merck announces $1.5M funding commitment over three years to BC Centre for Excellence in HIV/AIDS

Today, Merck is pleased to announce its $1.5 million funding commitment over three years to the BC Centre for Excellence in HIV/AIDS (BC-CfE) in support of its research program entitled "Seek and Treat for Optimal Prevention of HIV/AIDS", known as the "seek & treat" program, which will expand HIV treatment and care for hard-to-reach residents in Prince George and Vancouver's Downtown Eastside.

Researchers develop diagnostic test to detect enterovirus D68

Researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year. The outbreak caused infections at an unprecedented rate, with over 1,000 confirmed cases and 14 reported deaths nationwide, according to the Centers for Disease Control and Prevention.

Mrs Lisa Ann Gemma, CCC-SLP - Speech-Language Pathologist in Hope, RI